Skip to main content
logo
Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
10.02
-0.32 (-3.09%)
At close: Nov 10, 2026, 4:00 PM EST
9.54
-0.48 (-4.78%)
Pre-market: Nov 11, 2026, 7:17 AM EST

Biodesix Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
105.2188.571.3249.0938.2154.51
Revenue Growth
31.23%24.08%45.30%28.46%-29.89%19.64%
Gross Profit
86.6571.7855.7536.0824.0623.99
Operating Income
-19.65-27.77-34.26-41.3-50.51-39.32
Net Income
-27.08-35.27-42.93-52.15-65.45-43.16
Earnings Per Share
-2.80-4.67-6.64-12.70-31.09-31.54
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
28.4118.9926.2526.2843.0932.71
Total Debt
72.4472.8561.9860.6931.8510.01
Net Cash (Debt)
-44.03-53.87-35.73-34.4111.2422.7
Net Cash Growth
-----50.49%-33.93%
Net Cash Per Share
-4.55-7.13-5.52-8.385.3416.59

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-18.16-23.27-48.65-22.87-44.97-28.22
Capital Expenditures
-0.92-0.26-3.23-22.92-3.3-2.24
Free Cash Flow
-19.07-23.53-51.88-45.79-48.27-30.46
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
82.36%81.11%78.17%73.50%62.96%44.01%
Operating Margin
-18.68%-31.37%-48.03%-84.13%-132.17%-72.14%
Pretax Margin
-25.74%-39.85%-60.19%-106.23%-171.27%-79.18%
Profit Margin
-25.74%-39.85%-60.19%-106.23%-171.27%-79.18%
FCF Margin
-18.13%-26.59%-72.74%-93.28%-126.32%-55.89%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.060.613.123.394.602.62